Abstract
Three nitrosourea compounds [1–4], BCNU, CCNU, and methyl CCNU (MeCCNU) have demonstrated clinical efficacy in a variety of human malignancies including lung cancer, gastrointestinal tumors, lymphomas, melanomas, and brain tumors. But delayed and cumulative hematologic toxicity has been an obstacle to clinical use.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
